| 10/8/2024 | BKCVDDEMIGPV | Market Commentary: Cleveland-Cliffs drives by junkland; Patrick Industries weaker; Caesars improves
|
| 10/7/2024 | BKCVDDEMIGPV | Market Commentary: Primary resumes active pace; recent issues weaken in soft secondary; Caesars falls
|
| 10/7/2024 | BKCVHY | S&P rates Patrick Industries notes BB-
|
| 10/7/2024 | BKCVHY | Moody’s rates Patrick notes B3
|
| 10/7/2024 | BKCVHY | Fitch rates Patrick notes BB
|
| 10/4/2024 | BKCVHY | Fitch rates Patrick Industries, notes BB
|
| 9/27/2024 | BKCVHY | Moody’s changes Patrick view to positive
|
| 3/11/2022 | BKCVHY | S&P ups Patrick notes to BB-
|
| 12/8/2021 | CV | Market Commentary: Lucid convertibles on tap; Confluent, TechTarget eyed; Patrick Industries opens strong
|
| 12/8/2021 | CV | Market Commentary: Morning Commentary: Confluent, TechTarget on deck; Patrick Industries strong on debut
|
| 12/8/2021 | CV | New Issue: Patrick Industries prices $225 million seven-year convertible notes to yield 1.75%, up 30%
|
| 12/7/2021 | CV | Market Commentary: Patrick Industries convertibles on tap; Coupa Software notes slip; Norwegian Cruise up
|
| 12/7/2021 | CV | Market Commentary: Morning Commentary: Patrick Industries convertibles on tap; Coupa Software notes slip
|
| 12/7/2021 | CV | Patrick Industries launches $225 million seven-year convertibles at 1.75%-2.25%, up 27.5%-32.5%
|
| 4/14/2021 | BKCVDDEMIGPV | Market Commentary: United Airlines downsizes; Altice, Patrick on par-handles; CrownRock outperforms
|
| 4/13/2021 | BKCVHY | Moody's assigns Patrick notes B3
|
| 4/13/2021 | BKCVHY | S&P rates Patrick notes B+
|
| 1/13/2021 | BKCVHY | Moody’s upgrades Patrick Industries
|
| 7/21/2020 | BKCVDDHY | Moody’s ups Patrick secured rating, view to stable
|
| 4/8/2020 | BKCVDDHY | Moody’s pares Patrick Industries
|
| 3/26/2020 | BKCVHY | S&P puts Patrick Industries on watch
|
| 9/11/2019 | BKCVDDEMIGPV | Market Commentary: Primary at $8 billion: Tegna, Level 3 upsize; Beazer Homes, WPX, Extended Stay active
|
| 9/9/2019 | BKCVHY | S&P rates Patrick notes B+
|
| 1/23/2018 | CV | Market Commentary: Teekay eyes deal; Insmed seen as cheap; new paper active; Priceline gains on new CFO
|
| 1/22/2018 | CV | Patrick Industries greenshoe lifts 1% convertibles to $172.5 million
|
| 1/19/2018 | CV | Market Commentary: New convertibles from Patrick, Nutanix remain strong; Acorda, NXP, Blackhawk active
|
| 1/19/2018 | CV | Market Commentary: Morning Commentary: New paper from Patrick, Nutanix strong; Acorda active on buy-out speculation
|
| 1/18/2018 | CV | Market Commentary: Nutanix, Patrick Industries expand on debut; Exact Sciences rebounds; Coupa gains
|
| 1/18/2018 | CV | Market Commentary: Morning Commentary: New convertibles from Nutanix and Patrick Industries hit the market
|
| 1/18/2018 | CV | New Issue: Patrick prices upsized $150 million five-year convertibles to yield 1%, up 35%
|
| 1/17/2018 | CV | Market Commentary: Nutanix, Patrick convertibles eyed; Genocea prices; Exact Sciences is ‘murder today’
|
| 1/17/2018 | CV | Market Commentary: Morning Commentary: Nutanix, Patrick deals seen cheap, Exact Sciences is ‘murder today’
|
| 1/16/2018 | CV | Market Commentary: Nutanix, Patrick, Genocea Biosciences to price new deals; Coupa, Exact Sciences quiet; Blackhawk active
|
| 1/16/2018 | CV | Patrick talks $125 million five-year convertibles to yield 0.875% to 1.375%, up 32.5% to 37.5%
|
